M. Newton

Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy.

K. Tucker, L. West, P. Gehrig, 2020, Gynecologic oncology.

Hexamethylmelamine in ovarian cancer after failure of cisplatin-based multiple-agent chemotherapy.

G. Rosen, J. Lurain, M. Newton, 1987, Gynecologic oncology.

Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinoma

A. Secord, Wenchuan Sun, V. Bae-Jump, 2023, Annals of medicine.

Tissue factor–positive extracellular vesicles in plasma are not associated with venous thromboembolism in patients with ovarian cancer

N. Mackman, V. Bae-Jump, Y. Hisada, 2023, Research and practice in thrombosis and haemostasis.

AI-Augmented Clinical Decision Support in a Patient-Centric Precision Oncology Registry

J. Shrager, T. Stuhlmiller, Z. Osking, 2022, medRxiv.